Feasibility study: Development of a lead compound for specific mTORC1 inhibition - Texts

Home
Main Navigation
Content
Search
Help

Font Standard Bold
Login

Research unit

INNOSUISSE

Project number

28452.1 IP-LS

Project title

Feasibility study: Development of a lead compound for specific mTORC1 inhibition

Texts for this project

	German	French	Italian	English
Short description		-	-
Abstract		-	-

Inserted texts

Category	Text
Short description (German)	Feasibility study: Development of a lead compound for specific mTORC1 inhibition
Short description (English)	Feasibility study: Development of a lead compound for specific mTORC1 inhibition
Abstract (German)	The mammalian target of rapamycin complex 1 (mTORC1) is deregulated in multiple diseases. We aim to generate a lead compound that specifically inhibits mTORC1 by targeting substrate recruitment. We expect such a compound to be superior to current drugs for treating tuberous sclerosis complex.
Abstract (English)